Evidence map›Paper›PMID 38098210›Full record

ArticleESC heart failure2024

Treatment patterns and trajectories in patients after acute heart failure hospitalization.

Ryo Nakamaru, Yasuyuki Shiraishi, Takashi Kohno, Yuji Nagatomo, Hiroki Akiyama, Yuki Motoya, Masato Fukui, Toshitaka Yajima, Tsutomu Yoshikawa, Shun Kohsaka

Abstract read
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Significance and perspective of establishing a female animal model for heart failure with preserved ejection fraction.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ryo NakamaruDepartment of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.ORCID https://orcid.org/0000-0002-0129-7219
Yasuyuki ShiraishiDepartment of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Takashi KohnoDepartment of Cardiovascular Medicine, Kyorin University Faculty of Medicine, Tokyo, Japan.
Yuji NagatomoDepartment of Cardiology, National Defense Medical College, Tokorozawa, Japan.
Hiroki AkiyamaAstraZeneca K.K., Osaka, Japan.
Yuki MotoyaOno Pharmaceutical Co., Ltd., Osaka, Japan.
Masato FukuiOno Pharmaceutical Co., Ltd., Osaka, Japan.
Toshitaka YajimaAstraZeneca K.K., Osaka, Japan.
Tsutomu YoshikawaDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
Shun KohsakaDepartment of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Funding

Health Labour Sciences Research Grant 14528506Japan Agency for Medical Research and Development 201439013CJapanese Circulation SocietyJapan Society for the Promotion of Science 16H05215Japan Society for the Promotion of Science 16K09469Japan Society for the Promotion of Science 17K09526Japan Society for the Promotion of Science 18K08056Japan Society for the Promotion of Science 18K15860Japan Society for the Promotion of Science 20H03915Japan Society for the Promotion of Science 20K08408Japan Society for the Promotion of Science 20K08482Japan Society for the Promotion of Science 21K08142Japan Society for the Promotion of Science 23591062Japan Society for the Promotion of Science 23K07584Japan Society for the Promotion of Science 23K15168Japan Society for the Promotion of Science 26461088Sakakibara Clinical Research Grant for Promotion of Sciences
6 · The paper itself

Abstract

aimsThe trajectories of systolic function after admission for acute heart failure (HF) and their effect on clinical outcomes have not been fully elucidated. We aimed to assess changes in left ventricular ejection fraction (LVEF) between the index and 1 year after discharge and to examine their prognostic implications. METHODS AND

resultsWe extracted data from a prospective multicentre registry of patients hospitalized for acute HF and identified 1636 patients with LVEF data at admission and 1 year after discharge. We categorized them into five groups based on LVEF changes: HF with unchanged-preserved EF [HFunc-pEF (EF ≥ 50%); N = 527, 32.2%], unchanged-mildly reduced EF [HFunc-mrEF (EF 41-49%); N = 86, 5.3%], unchanged-reduced EF [HFunc-rEF (EF ≤ 40%); N = 377, 23.0%], worsened EF (HFworEF; N = 83, 5.1%), and improved EF (HFimpEF; N = 563, 34.4%). We then evaluated the subsequent composite outcome of cardiovascular death and HF readmission. During 1 year after discharge, 53% of patients with HF with reduced EF and 67% of those with HF with mildly reduced EF (HFmrEF) transitioned to other categories, whereas 92% of those with HF with preserved EF (HFpEF) remained within the same category. Patients with HFimpEF were more likely to be younger and had relatively preserved renal function, whereas those with HFworEF were the oldest and had more comorbidities among the five groups. After multivariable adjustment, patients with HFimpEF and HFunc-pEF had a lower risk for composite outcomes when referenced to patients with HFunc-rEF [hazard ratio (95% confidence interval), P-value: 0.28 (0.16-0.49), P < 0.001, and 0.40 (0.25-0.63), P < 0.001, respectively]. Conversely, patients with HFunc-mrEF and HFworEF had a comparable risk [0.44 (0.18-1.07), P = 0.07, and 0.63 (0.29-1.39), P = 0.26, respectively].

conclusionsA substantial number of patients with HF experienced transitions to other categories after discharge. Notably, patients with decreased EF experienced a worse prognosis, even with slight decreases (e.g. HFpEF transitioning to HFmrEF). These findings emphasize the significance of longitudinal assessments of systolic function to better manage patients following acute decompensation.

Indexed as

Heart FailureVentricular Function, LeftHospitalizationHumansProspective StudiesStroke VolumeAcute heart failureLeft ventricular ejection fractionMortalityTrajectory

Identifiers

PMID38098210
PMCPMC10966272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.